A Phase 2 interventional study of AdiaVita stem cell therapy in children with autism spectrum disorder

Study Description

Testing whether stem cell therapy combined with glutathione treatment can improve autism symptoms in children better than glutathione treatment alone

Study Details

Registry ID:

NCT07304440

Conditions:

Autism Spectrum Disorder, Autism, ASD, Autism Spectrum Disorder (ASD)

Phase:

Phase 1

Target Enrollment:

100 participants

Start Date:

May 1, 2026

Age Range:

3–12 years

Healthy Volunteers:

No

Study Locations (2 sites)

• Adia Med Of Winter Park
  Winter Park, FloridaUnited States, United States
• The Lyday Center
  Green Bay, WisconsinUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →